Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lang, D.
Right arrow Articles by Epstein, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, D.
Right arrow Articles by Epstein, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 8 937-945
DOI: 10.1093/hmg/ddg107
© 2003 Oxford University Press

Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer

Deborah Lang and Jonathan A. Epstein*

Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Received January 23, 2003; Accepted February 15, 2003

The neurocristopathies encompass a spectrum of developmental disorders characterized by abnormalities of neural crest-derived structures. Neural crest cells are pluripotent progenitors and the mechanisms by which specific cell-fate decisions are regulated have emerged as an important field of study. Many neurocristopathies are characterized by defects in melanocyte differentiation that can result in pigmentation abnormalities and deafness. One example is Waardenburg syndrome that can be caused by mutations in the PAX3, SOX10 or MITF genes. Other neural crest-related disorders are associated with enteric ganglia defects, such as those caused by mutations in the SOX10 or c-RET genes. The Pax3 and Sox10 transcription factors can directly regulate both MITF and c-RET. Here, we show that Pax3 and Sox10 can physically interact and we map the interaction domains. We show that this interaction contributes to Pax3 and Sox10 synergistic activation of a conserved c-RET enhancer and it explains why Sox10 mutants that cannot bind to DNA retain the ability to activate this enhancer in the presence of Pax3. However, in the context of the MITF gene, Pax3 and Sox10 must each bind independently to DNA in order to achieve synergy. This difference is consistent with the different structures of the c-RET and MITF enhancers, and the different mechanisms by which Pax3 binds to these enhancers. These observations explain the phenotype in the mild form of Yemenite deaf–blind syndrome caused by specific SOX10 mutations in the HMG box that abrogate DNA binding without disrupting association with Pax3.

* To whom correspondence should be addressed at: 954 BRB II, 421 Curie Boulevard, Philadelphia, PA 19104, USA. Tel: +1 2158988731; Fax: +1 2155732094; Email: epsteinj{at}mail.med.upenn.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Kanno, M. K. Wu, D. S. Agate, B. J. Fanelli, N. Wagle, E. F. Scapa, C. Ukomadu, and D. E. Cohen
Interacting Proteins Dictate Function of the Minimal START Domain Phosphatidylcholine Transfer Protein/StarD2
J. Biol. Chem., October 19, 2007; 282(42): 30728 - 30736.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Yokoyama, K. Takeda, and S. Shibahara
Functional Difference of the SOX10 Mutant Proteins Responsible for the Phenotypic Variability in Auditory-Pigmentary Disorders
J. Biochem., October 1, 2006; 140(4): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. K. Mayanil, A. Pool, H. Nakazaki, A. C. Reddy, B. Mania-Farnell, B. Yun, D. George, D. G. McLone, and E. G. Bremer
Regulation of Murine TGFbeta2 by Pax3 during Early Embryonic Development
J. Biol. Chem., August 25, 2006; 281(34): 24544 - 24552.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. Bondurand, D. Natarajan, A. Barlow, N. Thapar, and V. Pachnis
Maintenance of mammalian enteric nervous system progenitors by SOX10 and endothelin 3 signalling
Development, May 15, 2006; 133(10): 2075 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Wissmuller, T. Kosian, M. Wolf, M. Finzsch, and M. Wegner
The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors.
Nucleic Acids Res., January 1, 2006; 34(6): 1735 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
F. Puppo, M. Musso, D. Pirulli, P. Griseri, T. Bachetti, S. Crovella, G. Patrone, I. Ceccherini, and R. Ravazzolo
Comparative genomic sequence analysis coupled to chromatin immunoprecipitation: a screening procedure applied to search for regulatory elements at the RET locus
Physiol Genomics, November 17, 2005; 23(3): 269 - 274.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. E. Owens, K. W. Broman, T. Wiltshire, J. B. Elmore, K. M. Bradley, J. R. Smith, and E. M. Southard-Smith
Genome-wide linkage identifies novel modifier loci of aganglionosis in the Sox10Dom model of Hirschsprung disease
Hum. Mol. Genet., June 1, 2005; 14(11): 1549 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Garcia-Barcelo, R. W. Ganster, V. C.H. Lui, T. Y.Y. Leon, M.-T. So, A. M.F. Lau, M. Fu, M.-H. Sham, J. Knight, M. S. Zannini, et al.
TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease
Hum. Mol. Genet., January 15, 2005; 14(2): 191 - 204.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.